SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
11-Mar-22 9:06 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 11-Mar-22 | Grant | 47,000 | -- | -- | 38% 122.18K to 169.18K | |
15-Mar-21 7:24 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 12-Mar-21 | Grant | 47,000 | -- | -- | 66% 70.85K to 117.85K | |
13-Mar-20 5:23 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-20 | Grant | 1,500 | $7.31 | $10,965.00 | 2% 67.85K to 69.35K | |
06-Sep-19 5:46 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-19 | Grant | 1,500 | $7.95 | $11,921.20 | 2% 96.13K to 97.63K | |
26-Mar-19 10:07 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-19 | Grant | 1,500 | $7.95 | $11,921.20 | 2% 94.63K to 96.13K | |
06-Feb-19 7:23 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 04-Feb-19 | Market Purchase | 227 | $14.13 | $3,207.51 | < 1% 88.57K to 88.8K | (29%) |
26-Apr-19 4:54 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 04-Feb-19 | Private Purchase | 343 | $11.26 | $3,862.18 | < 1% 95.78K to 96.13K | |
26-Mar-19 10:07 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-18 | Grant | 1,500 | $7.95 | $11,921.20 | 2% 93.13K to 94.63K | |
26-Mar-19 10:07 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Mar-18 | Grant | 1,500 | $8.03 | $12,048.80 | 2% 91.63K to 93.13K | |
26-Mar-19 10:07 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 05-Sep-17 | Grant | 1,500 | $9.90 | $14,853.80 | 2% 90.13K to 91.63K | 2% |
26-Mar-19 10:07 AM View: | Eiger BioPharmaceuticals, I... (EIGR) | 06-Mar-17 | Grant | 1,325 | $8.20 | $10,868.30 | 1% 88.8K to 90.13K | |
19-Aug-16 10:00 PM View: | Eiger BioPharmaceuticals, I... (EIGR) | 18-Aug-16 | Market Purchase | 1,562 | $15.70 | $24,523.40 | 2% 87.24K to 88.8K | (37%) |